Skip to main content
NATURECELL CO.,LTD. logo

NATURECELL CO.,LTD. — Investor Relations & Filings

Ticker · 007390 ISIN · KR7007390008 KO Manufacturing
Open in API
Filings indexed 273 across all filing types
Latest filing 2024-03-21 Annual Report
Country KR South Korea
Listing KO 007390

About NATURECELL CO.,LTD.

http://en.naturecell.co.kr/

NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) and explicitly states it is the '제 53 기' (53rd Fiscal Year) covering the period from '2023년 01월 01일' to '2023년 12월 31일'. It contains comprehensive sections including company overview, history, capital changes, governance, and detailed business operations. This structure and content align perfectly with the definition of an Annual Report (10-K). FY 2023
2024-03-21 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) by Naturecell regarding the 'Report of Holding a General Meeting of Shareholders on a Concentrated Date'. It explains the company's inability to avoid the 'concentrated date' for its AGM due to scheduling conflicts, as per KOSDAQ Association guidelines. Since this is a regulatory disclosure regarding meeting logistics and compliance rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains information regarding the solicitation of proxies for the upcoming Annual General Meeting (AGM) of NatureCell. It includes details about the meeting date, agenda items (such as approval of financial statements), and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2024-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Naturecell. It contains the meeting agenda, voting procedures, director activity reports, and summary financial statements. This type of document is specifically designed to provide shareholders with the necessary information to vote on company matters, which falls under the category of Proxy Solicitation & Information Statement.
2024-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Naturecell. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2024-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Nature Cell regarding a significant change in revenue or profit/loss structure (a mandatory disclosure in the Korean market). It provides a summary of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with the reasons for the change. It is not a full annual report (10-K) or an interim report (IR), but rather a specific regulatory disclosure of financial results. Since it does not fit into the other specific categories like 'Earnings Release' (which is typically a press release) or 'Annual Report', and it is a formal regulatory filing, 'RNS' is the most appropriate classification. FY 2023
2024-01-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.